← Browse by Condition
Medical Condition

chronic kidney disease receiving dialysis

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 3
NCT06933472 Phase 3
Recruiting

A Study of a Novel Iron-based Phosphate Binder AP301 in Patients With Hyperphosphatemia in the U.S. and China

Enrollment
264 pts
Location
United States, China
Sponsor
Alebund Pharmaceuticals
View Trial →